login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
BIOCEPT INC (BIOC) Stock News
NASDAQ:BIOC -
US09072V6002
-
Common Stock
0.4349
USD
-0.07 (-13.05%)
Last: 10/24/2023, 8:22:08 PM
0.39
USD
-0.04 (-10.32%)
After Hours:
10/24/2023, 8:22:08 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BIOC Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
GRI
ALVR
TTNP
ACRX
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
2 years ago - By: Benzinga
- Mentions:
LICY
WLGS
CBIO
ESMT
...
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
2 years ago - By: InvestorPlace
- Mentions:
LMDX
AKU
HARP
TGH
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
2 years ago - By: InvestorPlace
- Mentions:
SFT
RVLP
CNXA
INBS
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
2 years ago - By: InvestorPlace
- Mentions:
OPGN
SECO
RSLS
JAGX
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
2 years ago - By: Biocept, Inc.
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases
2 years ago - By: Biocept, Inc.
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
2 years ago - By: Biocept, Inc.
Biocept to Participate in the H.C. Wainwright Global Investment Conference
2 years ago - By: Biocept, Inc.
Biocept to Hold Business Update Conference Call on August 30, 2023
2 years ago - By: InvestorPlace
- Mentions:
SONN
MRNA
FRTX
TENX
...
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
2 years ago - By: Biocept, Inc.
Biocept Reports Second Quarter 2023 Financial Results
2 years ago - By: Biocept, Inc.
Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
2 years ago - By: InvestorPlace
- Mentions:
SVFD
MF
AGRI
BPTS
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
2 years ago - By: InvestorPlace
- Mentions:
SIMO
PACW
BGLC
LIAN
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Please enable JavaScript to continue using this application.